SV

Street Verdict

Analyst Scorecard

A record of what Aditya Arora said publicly, with the source. Not advice.

“Bullish on Glenmark, recommending it as a 'buy-on-dip' candidate for positional views at 1380, with a stop loss at 1280 and a target of 1480. He highlights the stock's potential for recovery within the resilient pharma sector.”

Aditya Arora’s track record (trackable calls only): 10 graded calls · 95% CI 31–83%

Glenmark Pharmaceuticals LimitedBullishCalled 17 Feb 2025Graded 28 Feb 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Entry: ₹1,380, as stated.

Target ₹1,480, stop ₹1,280, as stated.

No time frame is stated, so it is tracked until a close reaches ₹1,480 or ₹1,280: there is no fixed window.

The stop ₹1,280 was reached on a close before the target ₹1,480. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹1380 on 2025-02-18 (stated entry ₹1380, LEVEL_CMP entry, filled); stop ₹1280 breached at close ₹1278.95 on 2025-02-28. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Tracking Glenmark Pharmaceuticals Limited since this call

1-year tracking window
Read the original articleSee Aditya Arora’s full track record